Xeris Biopharma Holdings (XERS) Debt Ratio (2020 - 2026)
Xeris Biopharma Holdings' (XERS) quarterly Debt Ratio came in at 0.56 in Q1 2026, down 26.35% YoY from 0.77 in Q1 2025, and down 1.77% on a QoQ basis from 0.57 in Q4 2025.
Xeris Biopharma Holdings (XERS) Debt Ratio (2020 - 2026) Analysis & Trends
Xeris Biopharma Holdings (XERS) has 7 years of Debt Ratio data on file, last reported at 0.56 in Q1 2026.
- Quarterly Debt Ratio fell 26.35% year-over-year to 0.56 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.56 (down 26.35% YoY) and the FY2025 annual result came in at 0.57, down 24.92% from the prior year.
- Debt Ratio eased to 0.56 in Q1 2026, from 0.57 in the prior quarter.
- In the past five years, Debt Ratio ranged from a high of 0.77 in Q1 2025 to a low of 0.41 in Q1 2022.
- A 5-year average of 0.61 and a median of 0.62 in 2023 frame the typical range for Debt Ratio.
- The widest YoY moves for Debt Ratio: up 87.66% in 2022, down 31.6% in 2022.
- Tracing XERS's Debt Ratio over 5 years: stood at 0.54 in 2022, then advanced by 9.0% to 0.59 in 2023, then increased by 29.29% to 0.77 in 2024, then retreated by 24.92% to 0.57 in 2025, then declined by 1.77% to 0.56 in 2026.
- The last three Debt Ratio figures came in at 0.56 (Q1 2026), 0.57 (Q4 2025), and 0.59 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Debt Ratio (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | -0.13 |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 0.42 |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 0.60 |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 0.32 |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 0.38 |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 0.29 |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | 0.12 |
| 10 | Xeris Biopharma Holdings | 1.48 Bn | 1.36 Bn | 79.59 Mn | 0.77 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 0.77 |
| Mar 31, 2026 | 0.56 |
| Dec 31, 2025 | 0.57 |
| Sep 30, 2025 | 0.59 |
| Jun 30, 2025 | 0.65 |
| Mar 31, 2025 | 0.77 |
| Dec 31, 2024 | 0.77 |
| Sep 30, 2024 | 0.72 |
| Jun 30, 2024 | 0.70 |
| Mar 31, 2024 | 0.69 |
| Dec 31, 2023 | 0.59 |
| Sep 30, 2023 | 0.63 |
| Jun 30, 2023 | 0.62 |
| Mar 31, 2023 | 0.63 |
| Dec 31, 2022 | 0.54 |
| Sep 30, 2022 | 0.46 |
| Jun 30, 2022 | 0.43 |
| Mar 31, 2022 | 0.41 |
| Dec 31, 2021 | 0.29 |
| Sep 30, 2021 | 0.67 |